Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not...
Use this information to figure out if this company is an ideal customer for you.
(781) 954-xxxx
8 Saint Marys Street
Boston, 02215
Leuko's CEO is Carlos Castro González
Leuko's CTO is Ian Butterworth
Leuko's HQ is located at 8 Saint Marys Street, Boston
Leuko's phone number is (781) 954-xxxx
Leuko's official website is leuko.com
Leuko's revenue is $1M - $5M
Leuko has 51 - 200 employees
Leuko is in the industry of: Medical Device